RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by RAPT Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for RAPT Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gray Mary Ann | Director | 0 | Mar 5, 2026 | 2 |
| Dombkowski Ashley L. | Director | 0 | Mar 5, 2026 | 2 |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | 0 | Mar 5, 2026 | 1 |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | 0 | Mar 5, 2026 | 1 |
| Braunstein Scott | Director | 0 | Mar 5, 2026 | 2 |
| Wong Brian Russell | PRESIDENT AND CEO | 0 | Mar 5, 2026 | 1 |
| Lyons-Williams Lori | Director | 0 | Mar 5, 2026 | 2 |
| Giordano Michael F | Director | 0 | Mar 5, 2026 | 2 |
| Kozick Linda | Director | 0 | Mar 5, 2026 | 2 |
| Ho William | CHIEF MEDICAL OFFICER | 15,020 | Jun 24, 2025 | 0 |
| Robbins Wendye | Director | 6,500Indirect | Apr 2, 2025 | 0 |
| Column Group II, LP | Other: Former 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group IV-A, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group IV, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group IV GP, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| TCG IV GP, LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Goeddel David V | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Svennilson Peter | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Kutzkey Tim | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group II GP, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi Capital, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi Management, LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi Capital II, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi II Management, LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Rieflin William JL | Director | – | May 23, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 (view filing)4:09 PM ET | Sep 1-2 | 2 days | Goeddel David V and 9 others10% Owner | SSale | −68.8K | $35.34 | −$2.43M | −100.0%0 after | 6 lots |
| Aug 25, 2021 (view filing) | Aug 23-24 | 2 days | Robbins WendyeDirector | PPurchase | +2.00K | $31.28 | +$62.6K | New position2.00K after | 6 lots |
| Aug 24, 2021 (view filing)8:52 PM ET | Aug 20-24 | 4 days | Goeddel David V and 9 others10% Owner | SSale | −95.7K | $31.30 | −$3.00M | −100.0%0 after | 18 lots |
| Aug 23, 2021 (view filing) | Aug 20 | 3 days | Robbins WendyeDirector | PPurchase | +600 | $29.53 | +$17.7K | +7.7%8.40K after | 2 lots |
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Ho WilliamChief Medical Officer | SSale | −1.00K | $32.07 | −$32.1K | −1.4%68.1K after | |
| Aug 12, 2021 (view filing) | Aug 11 | 1 day | Brockstedt Dirk G.Chief Scientific Officer | SSale | −2.65K | $31.19 | −$82.6K | −11.8%19.8K after | |
| Aug 3, 2021 (view filing) | Aug 2 | 1 day | Ho WilliamChief Medical Officer | SSale | −1.00K | $30.52 | −$30.5K | −1.5%64.7K after | |
| Jul 16, 2021 (view filing) | Jul 15 | 1 day | Ho WilliamChief Medical Officer | SSale | −1.00K | $30.23 | −$30.2K | −1.7%57.5K after | |
| Jul 13, 2021 (view filing) | Jul 12 | 1 day | Brockstedt Dirk G.Chief Scientific Officer | SSale | −2.65K | $33.53 | −$88.8K | −11.8%19.8K after | |
| Jul 8, 2021 (view filing) | Jul 7 | 1 day | Robbins WendyeDirector | PPurchase | +1.00K | $30.18 | +$30.2K | +14.7%7.80K after | 2 lots |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Ho WilliamChief Medical Officer | SSale | −1.00K | $31.75 | −$31.8K | −1.7%58.5K after |